Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma

Name: Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma
Creator: ClinicalTrials.gov
Published: 2026-07-12T01:58:48+08:00

DataMed2026-07-12 收录

肾细胞癌治疗

联合药物临床试验

数据链接：

https://datamed.org/dataset/28fe7ebf-cad8-447f-b496-918da05bdc45 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study was to determine the maximum tolerated dose, safety, and effectiveness of lenalidomide (CC-5013) administered in combination with sunitinib as treatment for patients with renal cell carcinoma.

提供机构：

ClinicalTrials.gov

Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Cell Carcinoma

资源简介：

相关数据集